• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影像学无法检测到的潜伏性肺淋巴细胞浸润提示需要早期糖皮质激素治疗:COVID-19 肺炎伴淋巴细胞减少症快速进展的尸检病例。

Radiologically Undetectable Latent Pulmonary Lymphocyte Infiltration Suggesting the Need for Early Glucocorticoid Therapy: An Autopsy Case of Rapidly Progressive COVID-19 Pneumonia with Lymphopenia.

机构信息

Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Japan.

Department of Pathology, Tokyo Metropolitan Tama Medical Center, Japan.

出版信息

Intern Med. 2021 Jul 1;60(13):2145-2148. doi: 10.2169/internalmedicine.7234-21. Epub 2021 May 14.

DOI:10.2169/internalmedicine.7234-21
PMID:33994439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8313926/
Abstract

We herein report a fatal case of coronavirus disease 2019 (COVID-19) pneumonia with rapid progression of respiratory failure and lymphopenia. Excessive recruitment and sequestration of lymphocytes in the lung were suggested as the pathophysiology underlying COVID-19-associated lymphopenia. Interestingly, the autopsy in this case revealed lymphocytic infiltration in the lungs even at sites that appeared normal on autopsy imaging. These findings suggest that in COVID-19 cases with risk factors of severe exacerbation, early glucocorticoid administration should be considered, especially if lymphopenia is present, even if the imaging findings show only mild abnormalities.

摘要

我们在此报告一例新冠肺炎(COVID-19)肺炎致死病例,其呼吸衰竭和淋巴细胞减少迅速进展。过度募集和隔离淋巴细胞被认为是 COVID-19 相关淋巴细胞减少症的病理生理学基础。有趣的是,本病例尸检显示,即使在尸检影像学显示正常的部位,肺部也存在淋巴细胞浸润。这些发现提示在 COVID-19 病例中,如果存在糖皮质激素治疗的风险因素,应考虑早期应用,特别是如果存在淋巴细胞减少症,即使影像学表现仅轻度异常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e4/8313926/037750d0caef/1349-7235-60-2145-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e4/8313926/8550a46797dc/1349-7235-60-2145-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e4/8313926/4b6021b64f9f/1349-7235-60-2145-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e4/8313926/84f9f9756e29/1349-7235-60-2145-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e4/8313926/ae94e1893ca4/1349-7235-60-2145-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e4/8313926/037750d0caef/1349-7235-60-2145-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e4/8313926/8550a46797dc/1349-7235-60-2145-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e4/8313926/4b6021b64f9f/1349-7235-60-2145-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e4/8313926/84f9f9756e29/1349-7235-60-2145-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e4/8313926/ae94e1893ca4/1349-7235-60-2145-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e4/8313926/037750d0caef/1349-7235-60-2145-g005.jpg

相似文献

1
Radiologically Undetectable Latent Pulmonary Lymphocyte Infiltration Suggesting the Need for Early Glucocorticoid Therapy: An Autopsy Case of Rapidly Progressive COVID-19 Pneumonia with Lymphopenia.影像学无法检测到的潜伏性肺淋巴细胞浸润提示需要早期糖皮质激素治疗:COVID-19 肺炎伴淋巴细胞减少症快速进展的尸检病例。
Intern Med. 2021 Jul 1;60(13):2145-2148. doi: 10.2169/internalmedicine.7234-21. Epub 2021 May 14.
2
Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms.淋巴细胞减少症是 COVID-19 患者重要的免疫学异常:可能的机制。
Scand J Immunol. 2021 Feb;93(2):e12967. doi: 10.1111/sji.12967. Epub 2020 Sep 14.
3
Is lymphopenia different between SARS and COVID-19 patients?淋巴细胞减少症在 SARS 和 COVID-19 患者中是否不同?
FASEB J. 2021 Feb;35(2):e21245. doi: 10.1096/fj.202002512.
4
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.严重急性呼吸综合征冠状病毒 2 在 COVID-19 死亡患者肺部、气道和血管内皮中的复制和嗜性的证据:一项尸检病例系列研究。
J Infect Dis. 2021 Mar 3;223(5):752-764. doi: 10.1093/infdis/jiab039.
5
[Pathological changes of fatal coronavirus disease 2019 (COVID-19) in the lungs: report of 10 cases by postmortem needle autopsy].[2019年新型冠状病毒肺炎(COVID-19)致死病例肺部病理改变:经皮针吸尸检10例报告]
Zhonghua Bing Li Xue Za Zhi. 2020 Jun 8;49(6):568-575. doi: 10.3760/cma.j.cn112151-20200405-00291.
6
Transient Lymphopenia and Interstitial Pneumonia With Endotheliitis in SARS-CoV-2-Infected Macaques.感染 SARS-CoV-2 的猕猴中出现短暂性淋巴细胞减少症和间质性肺炎伴内皮炎。
J Infect Dis. 2020 Oct 13;222(10):1596-1600. doi: 10.1093/infdis/jiaa486.
7
Clinical and pathological investigation of patients with severe COVID-19.严重 COVID-19 患者的临床和病理研究。
JCI Insight. 2020 Jun 18;5(12):138070. doi: 10.1172/jci.insight.138070.
8
Apoptosis-induced T-cell lymphopenia is related to COVID-19 severity.细胞凋亡诱导的 T 细胞淋巴细胞减少与 COVID-19 严重程度有关。
J Med Virol. 2021 May;93(5):2867-2874. doi: 10.1002/jmv.26742. Epub 2021 Feb 23.
9
Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis.淋巴细胞减少症与严重的 2019 年冠状病毒病(COVID-19)感染相关:系统评价和荟萃分析。
Int J Infect Dis. 2020 Jul;96:131-135. doi: 10.1016/j.ijid.2020.04.086. Epub 2020 May 4.
10
Prostaglandin D as a mediator of lymphopenia and a therapeutic target in COVID-19 disease.前列腺素 D 作为 COVID-19 疾病中淋巴细胞减少症的介质和治疗靶点。
Med Hypotheses. 2020 Oct;143:110122. doi: 10.1016/j.mehy.2020.110122. Epub 2020 Jul 21.

本文引用的文献

1
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.地塞米松对中重度 COVID-19 相关急性呼吸窘迫综合征患者存活天数和无呼吸机天数的影响:CoDEX 随机临床试验。
JAMA. 2020 Oct 6;324(13):1307-1316. doi: 10.1001/jama.2020.17021.
2
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.COVID-19 重症患者全身使用皮质类固醇与死亡率的关联:一项荟萃分析。
JAMA. 2020 Oct 6;324(13):1330-1341. doi: 10.1001/jama.2020.17023.
3
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
COVID-19 重症患者中氢化可的松对 21 天死亡率或呼吸支持的影响:一项随机临床试验。
JAMA. 2020 Oct 6;324(13):1298-1306. doi: 10.1001/jama.2020.16761.
4
Pathogenesis of COVID-19-induced ARDS: implications for an ageing population.COVID-19 引发的 ARDS 的发病机制:对老龄化人口的影响。
Eur Respir J. 2020 Sep 24;56(3). doi: 10.1183/13993003.02049-2020. Print 2020 Sep.
5
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
6
Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician's perspective.皮质类固醇在新冠病毒疾病管理中的作用:一项系统评价及临床医生视角
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):971-978. doi: 10.1016/j.dsx.2020.06.054. Epub 2020 Jun 27.
7
Caution against corticosteroid-based COVID-19 treatment.谨防基于皮质类固醇的新冠病毒治疗方法。
Lancet. 2020 Jun 6;395(10239):1759-1760. doi: 10.1016/S0140-6736(20)30749-2. Epub 2020 May 25.
8
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度:一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.
9
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study.美国成年人短期口服皮质类固醇及其相关危害:基于人群的队列研究。
BMJ. 2017 Apr 12;357:j1415. doi: 10.1136/bmj.j1415.
10
Glucocorticoid-induced apoptosis of lymphoid cells.糖皮质激素诱导的淋巴细胞凋亡。
Int Arch Allergy Immunol. 1994 Dec;105(4):347-54. doi: 10.1159/000236781.